Evaluate Pharma offers clients forecasts of the pharmaceutical industry in its annual World Preview.
The top R&D focus areas and forecasted dollar amount:
1. Oncology ($91.1 billion)
2. Central nervous system ($31 billion)
3. Musculoskeletal ($19.9 billion)
4. Cardiovascular ($19.7 billion)
5. Immunomodulators ($15 billion)
6. Respiratory ($9.2 billion)
7. Gastro-Intestinal ($8.4 billion)
8. Systemic Anti-infectives ($8.2 billion)
9. Blood ($6.4 billion)
10. Sensory organs ( $4.9 billion)
11. Dermatology ($3.9 billion)
12. Endocrine ($3.9 billion)
13. Genito-Urinary ($2 billion)
14. Other ($4.1 billion)
More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders
